These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 7996454

  • 1. BIRM 270: a novel inhibitor of arachidonate release that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils.
    Farina PR, Graham AG, Hoffman AF, Watrous JM, Borgeat P, Nadeau M, Hansen G, Dinallo RM, Adams J, Miao CK.
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1418-26. PubMed ID: 7996454
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of arachidonoyl trifluoromethyl ketone on arachidonic acid release and lipid mediator biosynthesis by human neutrophils. Evidence for different arachidonate pools.
    Fonteh AN.
    Eur J Biochem; 2002 Aug; 269(15):3760-70. PubMed ID: 12153573
    [Abstract] [Full Text] [Related]

  • 3. Lipoxygenase products of arachidonic acid modulate biosynthesis of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by human neutrophils via phospholipase A2.
    Billah MM, Bryant RW, Siegel MI.
    J Biol Chem; 1985 Jun 10; 260(11):6899-906. PubMed ID: 3922982
    [Abstract] [Full Text] [Related]

  • 4. Separation of agonist-stimulated arachidonate mobilization from subsequent leukotriene B4 synthesis in human neutrophils: different effects of oleoylacetylglycerol and phorbol myristate acetate as priming agents.
    Rosenthal MD, Franson RC.
    J Cell Physiol; 1994 Sep 10; 160(3):522-30. PubMed ID: 8077290
    [Abstract] [Full Text] [Related]

  • 5. Effects of aristolochic acid on phospholipase A2 activity and arachidonate metabolism of human neutrophils.
    Rosenthal MD, Vishwanath BS, Franson RC.
    Biochim Biophys Acta; 1989 Jan 23; 1001(1):1-8. PubMed ID: 2536283
    [Abstract] [Full Text] [Related]

  • 6. Leukotriene B4 stimulates the release of arachidonate in human neutrophils via the action of cytosolic phospholipase A2.
    Burke JR, Davern LB, Gregor KR, Tramposch KM.
    Biochim Biophys Acta; 1997 Oct 30; 1359(1):80-8. PubMed ID: 9398088
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Phorbol myristate acetate and the calcium ionophore A23187 synergistically induce release of LTB4 by human neutrophils: involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway.
    Liles WC, Meier KE, Henderson WR.
    J Immunol; 1987 May 15; 138(10):3396-402. PubMed ID: 3033073
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The influence of acetylshikonin, a natural naphthoquinone, on the production of leukotriene B4 and thromboxane A2 in rat neutrophils.
    Hsu MF, Chang LC, Huang LJ, Kuo SC, Lee HY, Lu MC, Wang JP.
    Eur J Pharmacol; 2009 Apr 01; 607(1-3):234-43. PubMed ID: 19232341
    [Abstract] [Full Text] [Related]

  • 12. Granulocyte-macrophage colony-stimulating factor increases the synthesis of leukotriene B4 by human neutrophils in response to platelet-activating factor. Enhancement of both arachidonic acid availability and 5-lipoxygenase activation.
    McColl SR, Krump E, Naccache PH, Poubelle PE, Braquet P, Braquet M, Borgeat P.
    J Immunol; 1991 Feb 15; 146(4):1204-11. PubMed ID: 1846895
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lung cancer cell lines inhibit leukotriene B4 production by human polymorphonuclear leukocytes at the level of phospholipase A2.
    Abe M, Matsuki H, Domae M, Kuwata H, Kudo I, Nakanishi Y, Hara N, Mitsuyama T, Furukawa T.
    Am J Respir Cell Mol Biol; 1996 Nov 15; 15(5):565-73. PubMed ID: 8918363
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.
    McDonald PP, McColl SR, Braquet P, Borgeat P.
    Br J Pharmacol; 1994 Mar 15; 111(3):852-60. PubMed ID: 8019762
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of lipid mediator biosynthesis in human inflammatory cells by BIRM 270.
    Parks TP, Hoffman AF, Homon CA, Graham AG, Lazer ES, Chilton FH, Borgeat P, Raible D, Schulman E, Bass DA.
    Agents Actions Suppl; 1995 Mar 15; 46():139-46. PubMed ID: 7610984
    [Abstract] [Full Text] [Related]

  • 19. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
    Lee TH, Mencia-Huerta JM, Shih C, Corey EJ, Lewis RA, Austen KF.
    J Clin Invest; 1984 Dec 15; 74(6):1922-33. PubMed ID: 6096400
    [Abstract] [Full Text] [Related]

  • 20. Ionophore A23187-induced leukotriene biosynthesis in equine granulocytes-neutrophils, but not eosinophils require exogenous arachidonic acid.
    Lindberg A, Tornhamre S, Mugnai S, Lindgren J.
    Biochim Biophys Acta; 1998 Mar 30; 1391(2):247-55. PubMed ID: 9555040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.